Journal of Dental Implant Research 2020; 39(4): 43-47  
Treatment of medication-related osteonecrosis of the jaw around the dental implant in a patient with multiple myeloma: a case report
Minyeong Youn, Youngjae Yee, Jun-Young Kim
Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry, Seoul, Korea
Correspondence to: Jun-Young Kim, https://orcid.org/0000-0002-6596-6135
Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. Tel: +82-2-228-3134, Fax: +82-2-227-7825, E-mail: jyomfs@yuhs.ac
Received: October 30, 2020; Revised: November 16, 2020; Accepted: November 16, 2020; Published online: December 30, 2020.
© The Korean Academy of Implant Dentistry. All rights reserved.

This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
The management of medication-related osteonecrosis of the jaw (MRONJ) around a dental implant is difficult. Conservative treatment is recommended; however, patients do not exhibit improvement. Thus, several adjunctive therapies have been introduced. Herein, we describe a case of MRONJ around a dental implant in a 68-year-old man. Owing to the patient’s history of multiple myeloma, treatment with teriparatide was contraindicated. We achieved successful results with hyperbaric oxygen therapy and surgical intervention. Clinicians treating patients with MRONJ should conduct a thorough examination before selecting the modalities of adjuvant therapy, thereby establishing a solid treatment strategy.
Keywords: Osteonecrosis of the jaw, Dental implant, Multiple myeloma, Bisphosphonate


This Article

e-submission

Archives

Indexed/Covered by

  • renew
  • banner_koreatoothbank